Skip to content
★ Sign in to follow
JT

James T. Lenehan

Board Director
Director
Medtronic plcMedtronic IncTalecris Biotherapeutics Holdings Corp.
Total declarations
39
Companies
3
▲ Purchases (3 ops.)
€224k
▼ Sales (1 ops.)
€88k

Latest filing published 04 May 2021 for Medtronic plc.

Filing timeline

BuySale
James T. Lenehan

Insider track record

Disclosed buys
3
Disclosed sells
1
Signal history

Closed purchases

Market purchases
3
Positive at T+90
33%
Median T+90
-11.2%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 23 Nov 2016 · 3637 days ago · €138k
    +10.2%
    Entry US$75.52 · Close at T+365 US$83.25
  • Filed 08 Jul 2010 · 5967 days ago · €72k
    -1.5%
    Entry 37.68 · Close at T+365 37.13

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

James T. Lenehan: trading record in brief

Filings by James T. Lenehan span 3 companies, the busiest being Medtronic plc, Medtronic Inc and Talecris Biotherapeutics Holdings Corp. The record holds 39 filings, for trades running from 31 August 2007 to 3 May 2021.

Both buying and selling appear: 3 purchases worth €224k, against 1 sale worth €88k. On balance, insiders were net buyers of €136k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 27 share grants and 6 option exercises.

The median purchase comes to €72k. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -11.2%. These figures describe past trades and do not predict future prices.

Most recently, on 4 May 2021, the filings show a share grant in Medtronic plc. The most recent open-market purchase was published on 23 November 2016, 3,637 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to James T. Lenehan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    1,334 shares0Ordinary SharesSEC:0001127602-21-015322:0
  • ◆
    DirectorExecutivesMedtronic plc
    55,367 USD11SEC
    426 shares@ US$129.974.8% of flowOrdinary SharesSEC:0001127602-21-014587:0
  • ◆
    DirectorExecutivesMedtronic plc
    38,962 USD19SEC
    393 shares@ US$99.14100.0% of flowOrdinary SharesSEC:0001127602-20-014921:0
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    1,737 shares0Ordinary SharesSEC:0001127602-20-014690:0
  • ◇
    DirectorExecutivesMedtronic plc
    80,008 USD13SEC
    1,813 shares@ US$44.1322.3% of flowOrdinary SharesSEC:0001127602-19-029170:0
  • ◆
    DirectorExecutivesMedtronic plc
    80,069 USD13SEC
    744 shares@ US$107.6222.3% of flowOrdinary SharesSEC:0001127602-19-029170:1
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    2,002 shares0Ordinary SharesSEC:0001127602-19-021493:0
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    2,002 shares0Ordinary SharesSEC:0001127602-19-016732:0
  • ◆
    DirectorExecutivesMedtronic plc
    38,099 USD12SEC
    429 shares@ US$88.8110.4% of flowOrdinary SharesSEC:0001127602-19-016732:1
  • ◇
    DirectorExecutivesMedtronic plc
    80,023 USD13SEC
    2,671 shares@ US$29.9621.5% of flowOrdinary SharesSEC:0001127602-19-010036:0
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    2,184 shares0Ordinary SharesSEC:0001127602-18-015926:0
  • ◆
    DirectorExecutivesMedtronic plc
    49,902 USD11SEC
    616 shares@ US$81.014.6% of flowOrdinary SharesSEC:0001127602-18-015926:1
  • ◇
    DirectorExecutivesMedtronic plc
    80,041 USD12SEC
    1,590 shares@ US$50.347.2% of flowOrdinary SharesSEC:0001127602-18-011591:0
  • ▼
    DirectorExecutivesMedtronic plc
    109,129 USD24SEC
    1,306 shares@ US$83.569.8% of flowOrdinary SharesSEC:0001127602-18-011591:1
  • ◇
    DirectorExecutivesMedtronic plc
    53,368 USD14SEC
    1,010 shares@ US$52.845.2% of flowOrdinary SharesSEC:0001127602-17-023489:0
  • ◆
    DirectorExecutivesMedtronic plc
    55,053 USD14SEC
    647 shares@ US$85.095.4% of flowOrdinary SharesSEC:0001127602-17-019836:0
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    2,090 shares0Ordinary SharesSEC:0001127602-17-016600:0
  • ◇
    DirectorExecutivesMedtronic plc
    43,366 USD13SEC
    801 shares@ US$54.144.6% of flowOrdinary SharesSEC:0001127602-17-001264:1
  • ◇
    DirectorExecutivesMedtronic plc
    140,006 USD14SEC
    2,586 shares@ US$54.1414.8% of flowOrdinary SharesSEC:0001127602-17-001264:0
  • ▲
    DirectorExecutivesMedtronic plc
    146,540 USD13SEC
    2,000 shares@ US$73.2715.3% of flowOrdinary SharesSEC:0001127602-16-068289:0
    Canonical exit: 21 Feb 2017 (T+90)
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    2,206 shares0Ordinary SharesSEC:0001127602-16-051013:0
  • ◆
    DirectorExecutivesMedtronic plc
    13,189 USD11SEC
    166 shares@ US$79.451.3% of flowOrdinary SharesSEC:0001127602-16-050258:0
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    1,387 shares0Ordinary SharesSEC:0001246360-15-001874:0
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    563 shares0Ordinary SharesSEC:0001246360-15-001874:1
  • ◆
    DirectorExecutivesMedtronic plc
    0SEC
    33,489 sharesOrdinary SharesSEC:0001209191-15-007312:0

25 of 38 declarations